SecBot SecBot
3 ·Filed May 19, 2026

IMUX

IMMUNIC, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001193805-26-000660
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This filing is purely administrative and carries no trading signal. Monitor for future Form 4 filings from Bonney, which would indicate actual insider buying or selling.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
IMUX ▲ +39.05% at T+60d
NEUTRAL call +39.05% · α vs SPY +34.04% · entry $11.55 → $16.06
Entry = T+0 close
May 19, 2026
via day close
T+1d
+6.49%
call +6.49% · α +6.30%
$12.30
settled 5mo ago
T+5d
+29.61%
call +29.61% · α +27.81%
$14.97
settled 5mo ago
T+20d
+22.94%
call +22.94% · α +22.20%
$14.20
settled 4mo ago
T+60d
+39.05%
call +39.05% · α +34.04%
$16.06
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Michael W. Bonney filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting no securities beneficially owned in Imunic, Inc. This is a routine filing required upon becoming a reporting person (e.g., director or officer) and has no material impact on the company's operations or stock.

Key Facts

  • Michael W. Bonney filed a Form 3 initial statement of beneficial ownership on May 19, 2026, for the period ending May 16, 2026.
  • The filing reports zero securities beneficially owned by Bonney in Imunic, Inc.
  • A power of attorney was also filed, appointing attorneys from Dentons US LLP to handle future SEC filings on Bonney's behalf.
  • The filing is administrative and does not involve any transaction, change in ownership, or material event.

Financial Impact

No financial impact — no securities owned or transacted.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193805-26-000660
Document: 0001193805-26-000660-index-headers.html0001193805-26-000660
Document: 0001193805-26-000660-index.html0001193805-26-000660
Document: 0001193805-26-000660.txt0001193805-26-000660
11 reports for IMUX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMUX — sortable, filterable
TypeNow
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$12.19awaiting T+60—$7.60 (−37.68%)
Aug 11, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$15.48awaiting T+60—$7.60 (−50.93%)
Jul 14, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$14.69 $7.63▼ −48.06%▼ −51.44%$7.60 (−48.29%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$15.37 $9.37▼ −39.04%▼ −42.60%$7.60 (−50.58%)
May 19, 2026
22w ago
3
NEUTRAL ★ 2/10
$11.55 $16.06▲ +39.05%▲ +34.04%$7.60 (−34.23%)
May 19, 2026
23w ago
8-K
NEUTRAL ★ 3/10
$11.60 $16.58▲ +42.93%▲ +36.64%$7.60 (−34.51%)
Apr 30, 2026
25w ago
S-3/A
BEARISH ★ 8/10
$9.65 $13.34▼ −38.24%▼ −35.17%$7.60 (+21.28%)
Apr 23, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$9.18 $15.00▲ +63.40%▲ +58.38%$7.60 (−17.25%)
Apr 14, 2026
27w ago
8-K
NEUTRAL ★ 4/10
$11.10 $14.77▲ +33.06%▲ +24.93%$7.60 (−31.56%)
Apr 10, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$12.20 $14.77▲ +21.07%▲ +12.14%$7.60 (−37.74%)
Showing 10 of 11

US Market Status

Market Open — Closes in 5h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026